Preparation and Activity Analysis of Recombinant Human High-Density Lipoprotein
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2012 |
---|---|
Erschienen: |
2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Assay and drug development technologies - 10(2012), 5 vom: 1. Okt., Seite 485-492 |
Beteiligte Personen: |
Su, Manman [VerfasserIn] |
---|
Umfang: |
7 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1904477941 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1904477941 | ||
003 | DE-627 | ||
005 | 20230515213218.0 | ||
007 | tu | ||
008 | 121010s2012 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a sw121005_1 |
035 | |a (DE-627)OLC1904477941 | ||
035 | |a (DE-599)GBVOLC1904477941 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 610 |
084 | |a PHARM |2 fid | ||
100 | 1 | |a Su, Manman |e verfasserin |4 aut | |
245 | 1 | 0 | |a Preparation and Activity Analysis of Recombinant Human High-Density Lipoprotein |
264 | 1 | |c 2012 | |
300 | |a 7 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Chang, Weiqin |4 oth | |
700 | 1 | |a Shi, Kaiyao |4 oth | |
700 | 1 | |a Wang, Dingding |4 oth | |
700 | 1 | |a Wang, Mingxing |4 oth | |
700 | 1 | |a Xu, Tianmin |4 oth | |
700 | 1 | |a Yan, Weiqun |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Assay and drug development technologies |d Larchmont, NY : Liebert, 2003 |g 10(2012), 5 vom: 1. Okt., Seite 485-492 |w (DE-627)490225683 |w (DE-600)2192373-5 |w (DE-576)435554492 |x 1540-658X |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2012 |g number:5 |g day:1 |g month:10 |g pages:485-492 |g extent:7 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |d 10 |j 2012 |e 5 |b 1 |c 10 |h 485-492 |g 7 |